Mats Carlsson

1.2k total citations
34 papers, 922 citations indexed

About

Mats Carlsson is a scholar working on Genetics, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mats Carlsson has authored 34 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 13 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mats Carlsson's work include Chronic Lymphocytic Leukemia Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Mats Carlsson is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunodeficiency and Autoimmune Disorders (6 papers). Mats Carlsson collaborates with scholars based in Sweden, Italy and United Kingdom. Mats Carlsson's co-authors include Kenneth Nilsson, Anders Rosén, M Schena, Gianluca Gaïdano, Davide Gottardi, F. Caligaris Cappio, P. Matsson, Christer Sundström, Ola Söderberg and B. R. Srinivasa and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and International Journal of Cancer.

In The Last Decade

Mats Carlsson

34 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mats Carlsson Sweden 17 392 378 336 180 152 34 922
G. Delespesse Canada 14 262 0.7× 518 1.4× 222 0.7× 185 1.0× 116 0.8× 30 1.1k
A Okos United States 13 600 1.5× 577 1.5× 184 0.5× 354 2.0× 124 0.8× 14 1.1k
Anne-Sophie Govaerts Belgium 17 75 0.2× 225 0.6× 172 0.5× 101 0.6× 140 0.9× 54 708
K. O. Kliche United States 10 130 0.3× 366 1.0× 266 0.8× 164 0.9× 282 1.9× 11 912
Teruaki Hamano Japan 16 101 0.3× 460 1.2× 240 0.7× 61 0.3× 130 0.9× 42 902
Mia J. Smith United States 18 91 0.2× 469 1.2× 215 0.6× 75 0.4× 66 0.4× 37 1.0k
Ahmed Aribi United States 17 202 0.5× 126 0.3× 382 1.1× 97 0.5× 211 1.4× 50 923
Bhaskar Srivastava United States 16 46 0.1× 752 2.0× 205 0.6× 85 0.5× 150 1.0× 27 1.0k
Rita Bisogni Italy 14 56 0.1× 239 0.6× 502 1.5× 62 0.3× 192 1.3× 25 868
A E Maluish United States 14 56 0.1× 570 1.5× 160 0.5× 76 0.4× 248 1.6× 16 875

Countries citing papers authored by Mats Carlsson

Since Specialization
Citations

This map shows the geographic impact of Mats Carlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Carlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Carlsson more than expected).

Fields of papers citing papers by Mats Carlsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mats Carlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Carlsson. The network helps show where Mats Carlsson may publish in the future.

Co-authorship network of co-authors of Mats Carlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Mats Carlsson. A scholar is included among the top collaborators of Mats Carlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Carlsson. Mats Carlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, John, Joy Conway, Michael J. Bennett, et al.. (2019). Quantitative Assessment of Mucociliary Clearance in Smokers with Mild-to-Moderate Chronic Obstructive Pulmonary Disease and Chronic Bronchitis from Planar Radionuclide Imaging Using the Change in Penetration Index. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 32(4). 175–188. 2 indexed citations
2.
3.
Carlsson, Mats. (2005). Management of geotechnical risks in infrastructure projects : an introductory study. 1 indexed citations
4.
Papadopoulos, Konstantinos I., Olle Melander, Marju Orho‐Melander, et al.. (2000). Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. Journal of Internal Medicine. 247(1). 71–77. 48 indexed citations
5.
Rosendahl, Alexander, et al.. (1999). Long-term survival and complete cures of B16 melanoma-carrying animals after therapy with tumor-targeted IL-2 and SEA. International Journal of Cancer. 81(1). 156–163. 19 indexed citations
6.
Söderberg, Ola, Ilse Christiansen, Gunnar Nilsson, Mats Carlsson, & Kenneth Nilsson. (1997). Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells. Leukemia. 11(8). 1298–1304. 10 indexed citations
7.
Söderberg, Ola, Ilse Christiansen, Mats Carlsson, & Kenneth Nilsson. (1997). CD40 Ligation Inhibits IL‐2 and SAC+IL‐2 Induced Proliferation in Chronic Lymphocytic Leukaemia Cells. Scandinavian Journal of Immunology. 45(6). 706–714. 10 indexed citations
8.
Hellman, Lars & Mats Carlsson. (1996). Allergy Vaccines. Clinical Immunotherapeutics. 6(2). 130–142. 7 indexed citations
9.
Rosén, Anders, Pia Lundman, Mats Carlsson, et al.. (1995). A CD4+ T cell line-secreted factor, growth promoting for normal and leukemic B cells, identified as thioredoxin. International Immunology. 7(4). 625–633. 90 indexed citations
10.
Nilsson, Gunnar, Mats Carlsson, Ian Jones, et al.. (1994). TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812.. PubMed. 81(1). 73–8. 27 indexed citations
11.
Wendel‐Hansen, Vidar, Johan Sällström, Pedro O. de Campos‐Lima, et al.. (1994). Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.. PubMed. 8(3). 476–84. 51 indexed citations
12.
Schena, Marina, Daniela Gottardi, Paolo Ghia, et al.. (1993). The Role of Bcl-2 in the Pathogenesis of B Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 11(3-4). 173–179. 30 indexed citations
13.
Carlsson, Mats, Ola Söderberg, & Kenneth Nilsson. (1993). Interleukin‐4 (IL‐4) Enhances Homotypic Adhesion of Activated B‐Chronic Lymphocytic Leukaemia (B‐CLL) Cells via a Selective Up‐Regulation of CD54. Scandinavian Journal of Immunology. 37(4). 515–522. 17 indexed citations
14.
Nilsson, Kenneth, Lennart Larsson, Ola Söderberg, et al.. (1992). On the Role of Endogenously Produced TNF-α and IL-6 as Regulators of Growth and Differentiation of B-Type Chronic Lymphocytic Leukemia Cells In Vitro. Current topics in microbiology and immunology. 182. 271–277. 5 indexed citations
15.
Nilsson, Kenneth, Lennart Larsson, & Mats Carlsson. (1992). Control of growth and differentiation of B-type chronic lymphocytic leukemia cells in vitro.. PubMed. 6 Suppl 3. 20S–21S. 1 indexed citations
16.
17.
Tötterman, Thomas H., Mats Carlsson, & Kenneth Nilsson. (1988). Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium: effects of interferon-alpha, -gamma and phorbol ester.. PubMed. 71(1). 187–92. 12 indexed citations
18.
Carlsson, Mats, et al.. (1987). Effects of recombinant interferon-alpha and -gamma on B-CLL cells in serum-free medium: expression of activation, differentiation, and CALLA antigens.. PubMed. 1(9). 667–72. 21 indexed citations
19.
Nilsson, Kenneth, Lars‐Gunnar Larsson, Mats Carlsson, et al.. (1986). Expression of c-myc and c-fos During Phorbol Ester Induced Differentiation of B-type Chronic Lymphocytic Leukemia Cells. Current topics in microbiology and immunology. 132. 280–289. 4 indexed citations
20.
Carlsson, Mats, et al.. (1966). Clinical Significance of Chronic Biologic False Positive Wassermann Reaction and “Antinuclear Factors”. Acta Medica Scandinavica. 180(4). 407–412. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Delespesse Breakdown of academic impact, for papers by A Okos Breakdown of academic impact, for papers by Anne-Sophie Govaerts Breakdown of academic impact, for papers by K. O. Kliche Breakdown of academic impact, for papers by Teruaki Hamano Breakdown of academic impact, for papers by Mia J. Smith Breakdown of academic impact, for papers by Ahmed Aribi Breakdown of academic impact, for papers by Bhaskar Srivastava Breakdown of academic impact, for papers by Rita Bisogni Breakdown of academic impact, for papers by A E Maluish
Rankless by CCL
2026